Health Alert:

COVID-19 Information

Karp Fellowship banner

The Karp Neuro-Oncology Fellowship

The Karp family provides a generous donation to support this fellowship, in memory of Henry “Hank" Karp.

It aims to inspire future neuro-oncologists to lead research and care innovations in the U.S. and around the world.

Why Choose to Apply to the Karp Fellowship?

The Neuro-Oncology Program at UPMC Hillman:

  • Supports our fellows through each stage of the process.
  • Has world-class research labs and dedicated support staff.
  • Provides access to a large and diverse patient population.

Our brain and nervous system cancer researchers are studying promising advances in:

  • Targeted therapies.
  • Immunotherapy.
  • Radiation treatments.

The goal is to improve the outcomes and quality of life of people with brain and nervous system cancers.

We thank the Karp family for their ongoing support in the future of neuro-oncology.

Who Can Apply to the Karp Neuro-Oncology Fellowship?

Anyone who's finished a residency program in adult or childhood neurology — both in the U.S. and abroad — can apply.

We'll also look at anyone wishing to pursue a career in academic neuro-oncology who has finished residencies in:

  • Medical or radiation oncology.
  • Children's cancer.
  • Neurosurgery.

The United Council for Neurologic Subspecialties accredits the one-year fellowship.

Fellows also have the option to stay on for a fully-funded second year. In doing so, they can advance world-class clinical trials and basic science research in brain and nervous system cancers.

For more about the fellowship and details on how to apply, email Jan Drappatz, MD, fellowship director, at drappatzj@upmc.edu.

Meet Our Current Karp Neuro-Oncology Fellow

Our first fellow is Michal Nisnboym, MD. She finished her neurology residency at the Tel-Aviv Sourasky Medical Center in Israel.

She's now completing her research year in Gary Kohanbash's lab in translational brain tumor immunotherapy research.

She starts her fellowship at UPMC Hillman in July 2022.